National MS Society: Large Observational Study Confirms Long-Term Benefits of MS Therapies for Reducing Relapses and Risk of Disability
January 08, 2021
January 08, 2021
NEW YORK, Jan. 8 (TNSRes) -- The National Multiple Sclerosis Society issued the following news:
An international team of investigators has reported results of an observational study involving over 14,000 people with relapsing-remitting MS, who were followed at various medical centers and countries for up to 15 years as part of the MSBase registry. They confirmed previous reports that long-term exposure to disease-modifying therapies reduces relapse activity and also prevents disabil . . .
An international team of investigators has reported results of an observational study involving over 14,000 people with relapsing-remitting MS, who were followed at various medical centers and countries for up to 15 years as part of the MSBase registry. They confirmed previous reports that long-term exposure to disease-modifying therapies reduces relapse activity and also prevents disabil . . .